Millennium Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.3M Sell
318,200
-96,700
-23% -$11.2M 0.02% 1037
2025
Q4
$43.7M Sell
414,900
-389,200
-48% -$36.5M 0.02% 899
2025
Q3
$67.5M Sell
804,100
-20,600
-2% -$1.7M 0.03% 672
2025
Q2
$65.3M Sell
824,700
-678,800
-45% -$54M 0.03% 655
2025
Q1
$135M Buy
1,503,500
+716,700
+91% +$66.9M 0.07% 255
2024
Q4
$78.3M Buy
786,800
+47,200
+6% +$4.87M 0.04% 516
2024
Q3
$84M Sell
739,600
-339,700
-31% -$40.4M 0.04% 522
2024
Q2
$134M Buy
1,079,300
+18,600
+2% +$2.4M 0.06% 314
2024
Q1
$140M Buy
1,060,700
+238,600
+29% +$29.4M 0.06% 311
2023
Q4
$89.6M Buy
822,100
+13,000
+2% +$1.35M 0.04% 469
2023
Q3
$83.3M Buy
809,100
+25,900
+3% +$2.79M 0.04% 441
2023
Q2
$90.4M Buy
783,200
+523,200
+201% +$59.4M 0.04% 406
2023
Q1
$27.7M Sell
260,000
-537,700
-67% -$58.1M 0.02% 1094
2022
Q4
$88.5M Sell
797,700
-456,400
-36% -$46.7M 0.05% 439
2022
Q3
$108M Sell
1,254,100
-140,600
-10% -$12.6M 0.06% 289
2022
Q2
$127M Buy
1,394,700
+415,400
+42% +$36.8M 0.08% 197
2022
Q1
$80.4M Buy
979,300
+761,500
+350% +$60M 0.04% 440
2021
Q4
$16.7M Sell
217,800
-887,300
-80% -$70.7M 0.01% 1619
2021
Q3
$75.2M Buy
+1,105,100
New +$84M 0.05% 424
2021
Q2
Sell
-410,921
Closed -$30.2M 6875
2021
Q1
$30.2M Sell
410,921
-57,849
-12% -$4.27M 0.02% 782
2020
Q4
$36.6M Sell
468,770
-509,119
-52% -$38.9M 0.03% 638
2020
Q3
$77.4K Buy
977,889
+125,236
+15% +$9.81M 0.1% 177
2020
Q2
$62.9M Buy
852,653
+425,069
+99% +$32M 0.09% 213
2020
Q1
$31.4M Buy
427,584
+265,982
+165% +$20.9M 0.07% 284
2019
Q4
$14M Sell
161,602
-81,220
-33% -$6.67M 0.02% 1094
2019
Q3
$19.5M Sell
242,822
-269,860
-53% -$21.6M 0.03% 799
2019
Q2
$41M Buy
+512,682
New +$39.3M 0.06% 422
2018
Q3
Sell
-440,160
Closed -$25.5M 4141
2018
Q2
$25.5M Buy
440,160
+94,320
+27% +$5.32M 0.03% 731
2018
Q1
$18M Buy
345,840
+83,840
+32% +$4.53M 0.02% 937
2017
Q4
$14.1M Buy
+262,000
New +$14.5M 0.02% 1110
2017
Q3
Sell
-565,920
Closed -$34.6M 3731
2017
Q2
$34.6M Buy
565,920
+534,480
+1,700% +$32.5M 0.06% 452
2017
Q1
$1.91M Hold
31,440
﹤0.01% 2043
2016
Q4
$1.77M Sell
31,440
-286,628
-90% -$16.8M ﹤0.01% 1944
2016
Q3
$18.9M Buy
318,068
+213,268
+204% +$12.5M 0.03% 606
2016
Q2
$5.76M Sell
104,800
-157,200
-60% -$8.37M 0.01% 1166
2016
Q1
$13.2M Buy
+262,000
New +$12.8M 0.03% 673
2015
Q4
Sell
-209,600
Closed -$9.88M 3651
2015
Q3
$9.88M Sell
209,600
-31,440
-13% -$1.67M 0.02% 939
2015
Q2
$13.1M Buy
+241,040
New +$13.5M 0.02% 820
2015
Q1
Sell
-524
Closed -$28K 3913
2014
Q4
$28K Sell
524
-160,658
-100% -$8.95M ﹤0.01% 3850
2014
Q3
$9.12M Buy
161,182
+149,444
+1,273% +$8.39M 0.02% 918
2014
Q2
$648K Buy
+11,738
New +$640K ﹤0.01% 2440
2014
Q1
Sell
-78,076
Closed -$3.73M 3735
2013
Q4
$3.73M Sell
78,076
-833,160
-91% -$38.1M 0.01% 1384
2013
Q3
$41.4M Buy
911,236
+598,513
+191% +$27.3M 0.13% 117
2013
Q2
$13.9M Buy
+312,723
New +$14M 0.04% 468

Other funds holding MRK

Millennium Management's MRK Position: Q1 2026 in Review

Millennium Management reduced its Merck (MRK) stake by 71% in Q1 2026, selling an estimated $558M and leaving 1,970,691 shares worth $237M. The position accounts for 0.1% of the portfolio, ranked #176.

Millennium Management first reported a position in MRK in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.33B in Q1 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Millennium Management held 1,970,691 shares of Merck worth $237M as of Q1 2026.
  • Millennium Management sold 4,829,660 Merck shares in Q1 2026, an estimated $558M.
  • Merck made up 0.1% of Millennium Management's portfolio in Q1 2026, its #176 holding.
  • Millennium Management first reported a position in Merck in Q2 2013 and has held it in 51 quarters since.
  • Millennium Management's Merck position peaked at $1.33B in Q1 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.